Polyrizon Ltd. (PLRZ) Stock

NASDAQ: PLRZHealthcare company in the biotechnology industry, based in Ra'anana, USA.

Polyrizon stock price chart

PLRZ interactive chart →

PLRZ stock quote & key statistics

Polyrizon earnings per share

Income →
Earnings per share

Polyrizon revenue & net income

Income →
RevenueNet income

Polyrizon annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$3.3M—
FY2024$0-$1.5M-$72.60
FY2023$0-$600,000—
FY2022$0-$779,000—

Fiscal year ending December 31. Source: company filings via EODHD.

About Polyrizon Ltd.

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.

Polyrizon stock FAQ

What is the Polyrizon stock ticker symbol?

Polyrizon Ltd. trades on the NASDAQ under the ticker symbol PLRZ.

What sector and industry is Polyrizon in?

Polyrizon Ltd. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Polyrizon have?

Polyrizon Ltd. has about 2 full-time employees.

What were Polyrizon's revenue and earnings last fiscal year?

Polyrizon reported revenue of $0 and net income of -$3.3M in fiscal 2025.

When did Polyrizon go public?

Polyrizon stock began trading on October 29, 2024.

Biotechnology stocks

All Healthcare stocks →